bcl-2 expression in endometrial hyperplasia and carcinoma

被引:33
|
作者
Niemann, TH
Trgovac, TL
McGaughy, VR
Vaccarello, L
机构
[1] ARTHUR G JAMES CANC HOSP,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,MED CTR,DIV GYNECOL ONCOL,COLUMBUS,OH 43210
关键词
D O I
10.1006/gyno.1996.0329
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The bcl-2 gene codes for a protein which functions to inhibit apoptotic cell death. bcl-2 overexpression was originally described in follicular lymphoma, but more recently bcl-2 expression has been observed in a variety of other human neoplasms. In this study we used immunohistochemistry to examine bcl-2 protein expression in endometrial hyperplasia and carcinoma. bcl-2 protein was observed in 4/4 cases of complex hyperplasia, 1/4 cases of complex atypical hyperplasia, and 10/29 cases of carcinoma. The staining observed in the cases of complex atypical hyperplasia and carcinoma was focal and less intense than the reactivity of normal proliferative endometrium. We conclude that bcl-2 protein is seldom overexpressed in complex atypical hyperplasia or carcinoma of the endometrium. Rather, in many cases of endometrial carcinoma bcl-2 expression appears to be decreased. (C) 1996 Academic Press, Inc.
引用
收藏
页码:318 / 322
页数:5
相关论文
共 50 条
  • [21] bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma
    Henderson, GS
    Brown, KA
    Perkins, SL
    Abbott, TM
    Clayton, F
    MODERN PATHOLOGY, 1996, 9 (04) : 430 - 438
  • [22] bcl-2 protein expression in endometrial carcinoma:: the lack of correlation with p53
    Miturski, R
    Semczuk, A
    Tomaszewski, J
    Jakowicki, J
    CANCER LETTERS, 1998, 133 (01) : 63 - 69
  • [23] Bcl-2 expression in male breast carcinoma
    A. Pich
    Elena Margaria
    Luigi Chiusa
    Virchows Archiv, 1998, 433 : 229 - 235
  • [24] BCL-2 EXPRESSION IN BREAST-CARCINOMA
    DOGLIONI, C
    TOS, APD
    LAURINO, L
    BARBARESCHI, M
    CHIARELLI, C
    VIALE, G
    LABORATORY INVESTIGATION, 1994, 70 (01) : A15 - A15
  • [25] Bcl-2 expression in male breast carcinoma
    Pich, A
    Margaria, E
    Chiusa, L
    VIRCHOWS ARCHIV, 1998, 433 (03) : 229 - 235
  • [26] The role of Bcl-2 in apoptotic process of non-atypical endometrial hyperplasia
    Cahyanti, R. D.
    Wijaya, I.
    Kristanto, H.
    13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY, 2010, : 227 - 231
  • [27] Comparison of B-cell lymphoma 2 (BCL-2) expression in disordered proliferative endometrium and simple endometrial hyperplasia
    Ghorbanniadelavar, Zahra
    Nadoushan, Mohammadreza Jalali
    Soltanipur, Masood
    REVISTA ESPANOLA DE PATOLOGIA, 2024, 57 (04): : 265 - 272
  • [28] p53 and BCL-2 as prognostic markers in endometrial carcinoma
    Appel, Marcia L. M.
    Edelweiss, Maria I.
    Fleck, James
    Rivero, Luis F.
    Rivoire, Waldemar A.
    Monego, Heleusa I.
    dos Reis, Ricardo
    PATHOLOGY & ONCOLOGY RESEARCH, 2008, 14 (01) : 23 - 30
  • [29] Bcl-2, BAX and apoptosis in endometrial hyperplasia after high dose gestagen therapy
    Oerbo, Anne
    Vereide, Anne Beate
    Kaino, Turid
    Sager, Georg
    VIRCHOWS ARCHIV, 2007, 451 (02) : 394 - 394
  • [30] Persistent expression of bcl-2 onco-protein in endometrial carcinoma correlates with hormone receptor positivity
    Zheng, W
    Feng, Y
    Gandhi, M
    Siu, S
    Hom, E
    Caputo, T
    Lauchlan, SC
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 (03) : 235 - 240